SIGN UP
LOG IN
I
00399
Innovative Pharmaceutical Biotec…
0.25
0.02+9.65%Opening13:51 07/07 HKT
OPEN/PREV CLOSE0.232/0.228
TODAY RANGE0.231-0.330
VOL22.23M
MARKET CAP461.44M
52 WEEK RANGE0.145-0.700
AVG VOL (3M)4.25M
% TURNOVER1.20%
TURNOVER5.94M
P/E (TTM)-1.334
% RANGE43.42%
EPS(TTM)-0.187
P/E(FORWARD)--
P/B-0.677
BVPS-0.369
DIVIDEND--
P/S227.273
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP461.44M
SHARES OUTSTANDING1.85B
NEXT EARNINGS--
FREE FLOAT1.85B
LOT SIZE5000
EX-DATE--
News
Press Releases
Financial Reports
Profile
Simply Wall St·01/03 22:07
We Believe That Innovative Pharmaceutical Biotech's (HKG:399) Weak Earnings Are A Good Indicator Of Underlying Profitability
Simply Wall St·12/01/2024 01:33
One Innovative Pharmaceutical Biotech Insider Raised Stake By 15% In Previous Year
Reuters·11/29/2024 13:55
INNOVATIVE PHARMACEUTICAL BIOTECH H1 REVENUE HKD 3 MILLION
Reuters·11/12/2024 16:08
BRIEF-Innovative Pharmaceutical Biotech Announces MoU For Possible Investment In Niraxx
Reuters·11/12/2024 13:19
INNOVATIVE PHARMACEUTICAL BIOTECH - TO INVEST IN NIRAXX. INC.
Same Industry
Name/Symbol
Change%
Price
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.